Bio Green Med Solution, Inc. (BGMS)
D
Pipeline Grade
Financial Position (from SEC Filings)
$3.1M
Cash & Equivalents
$0.3M
Quarterly Burn Rate
34 mo
Est. Cash Runway
$5M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-07-31 | Phase2 Readout | — |
| 2026-07-31 | Phase2 Readout | — |
| 2026-08-01 | Phase1 Readout | — |
| 2026-08-14 | Phase1 Readout | — |
| 2026-09-01 | Phase2 Readout | — |
| 2026-09-30 | Phase1 Readout | — |
| 2026-09-30 | Phase2 Readout | — |
| 2026-09-30 | Phase3 Readout | — |
| 2026-10-01 | Phase2 Readout | — |
| 2026-10-01 | Phase3 Readout | — |
| 2026-10-31 | Phase2 Readout | — |
| 2026-11-01 | Phase2 Readout | — |
| 2026-11-01 | Phase2 Readout | — |
| 2026-11-01 | Phase1 Readout | — |
| 2026-11-18 | Phase1 Readout | — |
| 2026-11-30 | Phase2 Readout | — |
| 2026-11-30 | Phase1 Readout | — |
| 2026-12-01 | Phase2 Readout | — |
| 2026-12-01 | Phase3 Readout | — |
| 2026-12-01 | Phase2 Readout | — |
Active Clinical Trials (50)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06985238 | Stratagen Quantitative Prostate MRI Platform Pilot Study | OTHER | Recruiting | 75 |
| NCT07656155 | Digital Phenotyping of High-Risk Chronic Ventilator-Dependent Patients | OTHER | Enrolling By Invitation | 30,500 |
| NCT07681466 | Chronology and Sequence of Premonitory Symptoms | OTHER | Recruiting | 500 |
| NCT06591806 | An Observational Study in Children and Adults With Stargardt Disease | OTHER | Active Not Recruiting | 80 |
| NCT07282561 | Role of Nutritional Status in Functional Recovery of Older Adults Undergoing Virtual Reality-augmented Shoulder Rehabili... | OTHER | Recruiting | 60 |
| NCT06543550 | Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis | PHASE4 | Recruiting | 70 |
| NCT06634654 | An Artificial Intelligence-based Approach in Total Knee Arthroplasty: From Inflammatory Responses to Personalized Medici... | OTHER | Recruiting | 197 |
| NCT07128108 | Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastograp... | OTHER | Recruiting | 225 |
| NCT07021911 | Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer | OTHER | Recruiting | 300 |
| NCT06094153 | Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function | OTHER | Active Not Recruiting | 108 |
| NCT07650136 | Method Comparison of Intelligent Fingerprinting Drug Screening System | OTHER | Recruiting | 144 |
| NCT07178002 | OM 85 to Prevent Respiratory Infections in Older At Risk Patients | PHASE4 | Active Not Recruiting | 360 |
| NCT07267845 | The Effect of α-GPC on Cognitive Function and Sports Performance | OTHER | Recruiting | 80 |
| NCT07435649 | Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used... | OTHER | Recruiting | 400 |
| NCT07061379 | Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Canc... | OTHER | Recruiting | 144 |
| NCT06389539 | Synbiotic to Attenuate Resorption of the Skeleton | OTHER | Recruiting | 220 |
| NCT07135596 | Effectiveness and Safety of OviTex® PRS in Breast Reconstruction | OTHER | Recruiting | 235 |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | OTHER | Recruiting | 50,000 |
| NCT05377307 | Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy | OTHER | Recruiting | 49 |
| NCT05833360 | Prospective Study of oncRNA Stratification of Cancer by Size and Stage | OTHER | Recruiting | 2,400 |
| NCT06628921 | The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study) | OTHER | Recruiting | 50 |
| NCT05759637 | Type 2 Diabetes, Obesity and Cortisol Excess | OTHER | Recruiting | 3,200 |
| NCT06860841 | Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM | PHASE4 | Active Not Recruiting | 16 |
| NCT06037941 | Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma | OTHER | Recruiting | 20 |
| NCT03308916 | Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers | OTHER | Recruiting | 6,500 |
| NCT06194968 | Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study | OTHER | Recruiting | 1,800 |
| NCT06842017 | Passive Exoskeletons for Assisting Patients With Shoulder Musculoskeletal Disorders | OTHER | Enrolling By Invitation | 15 |
| NCT06614166 | Food Trial to Evaluate the Kinetics of the Medical Foods SBD111 and SBD121 Persistence in Healthy Adults | OTHER | Active Not Recruiting | 40 |
| NCT06583876 | Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study | OTHER | Recruiting | 15 |
| NCT07021846 | Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer | OTHER | Recruiting | 132 |
| NCT07178119 | Bridging Technique Validation for Nasolabial Folds JN-BRIDGE-1 | OTHER | Recruiting | 60 |
| NCT06655272 | OM 85 to Prevent Respiratory Infections in Older At Risk Patients | PHASE4 | Recruiting | 360 |
| NCT05949593 | Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy | PHASE3 | Active Not Recruiting | 429 |
| NCT07554456 | A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizum... | PHASE3 | Recruiting | 90 |
| NCT06735391 | A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients... | PHASE3 | Recruiting | 516 |
| NCT06994195 | A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent ... | PHASE3 | Recruiting | 450 |
| NCT06838273 | A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mut... | PHASE3 | Recruiting | 720 |
| NCT06045806 | A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenali... | PHASE3 | Active Not Recruiting | 79 |
| NCT06316531 | A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast ... | PHASE3 | Active Not Recruiting | 274 |
| NCT06382129 | A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type No... | PHASE3 | Active Not Recruiting | 698 |
| NCT07441460 | A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer | PHASE3 | Recruiting | 1,800 |
| NCT06382142 | A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Met... | PHASE3 | Active Not Recruiting | 418 |
| NCT07518147 | A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Posit... | PHASE3 | Recruiting | 438 |
| NCT07354516 | Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension | PHASE3 | Active Not Recruiting | 60 |
| NCT07515079 | Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema | PHASE3 | Recruiting | 406 |
| NCT03789916 | SAPT Versus DAPT in Incomplete Revascularization After CABG | PHASE3 | Recruiting | 800 |
| NCT06127407 | Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treat... | PHASE3 | Recruiting | 136 |
| NCT06668961 | A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent ... | PHASE2 | Recruiting | 60 |
| NCT07118254 | A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RE... | PHASE2 | Recruiting | 15 |
| NCT03277729 | A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD2... | PHASE2 | Active Not Recruiting | 53 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.